Clostridioides difficile (C. diff) is a stealthy threat. It infects more than 500,000 people in the United States each year, ...

Recursion Pharmaceuticals stock drops as Q2 loss widens and pipeline shake-up continues, despite revenues boost from Sanofi ...

Novavax posted a surprise profit in Q2 2025, reporting GAAP EPS of $0.62 compared to an expected loss of $0.04 per share. Revenue (GAAP) was $239 million, well above the analyst estimate of $152.61 ...

When bacterial pathogens enter our bodies, they've got one goal-hunt for food to multiply. And during the process, they make us sick. Inside the Skaar ...

The Trump administration is decreasing funding for the development of mRNA (messenger RNA) vaccines, which were crucial in ...

As a kid, I remember having a rash after taking penicillin. To this day, my doctor prescribes something other than penicillin ...

St. John’s Health learned earlier this year that its rating was expected to drop from 5 to 4 stars. Although that hasn’t officially happened yet, hospital leaders are already discussing ...